These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35658379)

  • 1. [Exploratory study on detection of drug resistance of
    Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
    Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.
    Song J; Du W; Liu Z; Che J; Li K; Che N
    Microbiol Spectr; 2022 Feb; 10(1):e0135821. PubMed ID: 35138166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    Syed RR; Catanzaro DG; Colman RE; Cooney CG; Linger Y; Kukhtin AV; Holmberg RC; Norville R; Crudu V; Ciobanu N; Codreanu A; Seifert M; Hillery N; Chiles P; Catanzaro A; Rodwell TC
    J Clin Microbiol; 2023 Mar; 61(3):e0147822. PubMed ID: 36757183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
    BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients.
    Shi J; He G; Ning H; Wu L; Wu Z; Ye X; Qiu C; Jiang X
    Tuberculosis (Edinb); 2022 Jul; 135():102209. PubMed ID: 35550524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing.
    Park J; Jang W; Kim M; Kim Y; Shin SY; Park K; Kim MS; Shin S
    J Microbiol Methods; 2018 Feb; 145():1-6. PubMed ID: 29242075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ; Morlock GP; Sikes RD; Dalton TL; Metchock B; Starks AM; Hooks DP; Cowan LS; Plikaytis BB; Posey JE
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
    Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
    Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
    Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
    Safari M; Moghim S; Salehi M; Jafari R; Nasr Esfahani B
    Infect Genet Evol; 2020 Nov; 85():104468. PubMed ID: 32711076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis.
    Liang J; An H; Zhou J; Liu Y; Xiang G; Liu Y; Xing W; Gong W
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1851-1861. PubMed ID: 33792806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.